Stocks experienced mixed movements with notable gains in Dayforce, UnitedHealth, Novo Nordisk, GoodRx, and Sunrun, driven by acquisition talks, FDA approvals, and strategic partnerships, while other stocks like Intel and solar companies also saw significant activity ahead of upcoming earnings reports and policy speeches.
Dayforce's stock surged 24% on reports that private equity firm Thoma Bravo is in talks to acquire the company, which could be a move to go private amid undervaluation in public markets. The company, a player in the human capital management sector, has faced recent challenges but shows signs of growth potential, especially in large enterprise markets. Thoma Bravo's history of software acquisitions and its connection to Dayforce's former leadership suggest strategic interest in the company.
Shares of Dayforce surged 26.6% on reports that private equity firm Thoma Bravo may acquire the company, potentially taking it private in the coming weeks, leading to its biggest one-day gain since going public in 2018.
Thoma Bravo is in talks to acquire AI-driven HR software provider Dayforce in a deal valued at over $9 billion, aiming to take the company private amid ongoing software sector consolidation. The deal reflects Thoma Bravo's strategy of acquiring undervalued software firms with strong growth potential, as Dayforce's shares surged following the news.
Thoma Bravo is in negotiations to acquire Dayforce, a human resources management software provider, in a deal that could be announced soon, with the company potentially going private. Dayforce's shares surged in pre-market trading, and the deal reflects ongoing private equity activity despite challenges in the enterprise software market post-Covid-19. The acquisition would mark another strategic move by Thoma Bravo, which has been active in the digital assets and software space this year.